| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥356.7B | ¥374.7B | -4.8% |
| Operating Income | ¥27.9B | ¥26.0B | +7.3% |
| Ordinary Income | ¥29.3B | ¥26.6B | +10.0% |
| Net Income | ¥19.8B | ¥19.5B | +1.9% |
| ROE | 4.8% | 4.8% | - |
FY2025 Q3 cumulative results show revenue of 35.67B yen (YoY -4.8%), operating income of 2.79B yen (YoY +7.3%), ordinary income of 2.93B yen (YoY +10.0%), and net income attributable to owners of 1.98B yen (YoY +1.9%). Despite revenue contraction, profitability improved through cost management, with operating margin expanding to 7.8% from 6.9% in the prior year. The company recorded an impairment loss of 432M yen in the Collagen and Casing segment related to withdrawal from production of certain special specification products for overseas markets, representing a non-recurring factor that impacted net income by approximately 2.2% of revenue. Total assets increased to 71.54B yen from 70.17B yen, while equity strengthened to 41.02B yen, maintaining a solid equity ratio of 57.3%.
Revenue declined 4.8% YoY to 35.67B yen, driven primarily by contraction in the Collagen and Casing segment (down 3.9% to 6.78B yen) and Leather Related segment (down 21.2% to 4.46B yen). These decreases were partially offset by growth in Cosmetics segment revenue, which increased 8.0% to 6.25B yen, reflecting strong demand in the cosmetics market. The Gelatin Related segment, the largest revenue contributor at 26.1% of total sales, experienced a slight decline of 6.4% to 9.32B yen. Food and Other segment sales decreased 1.7% to 8.08B yen, while Leasing and Real Estate segment remained stable at 0.79B yen. On the profit side, operating income improved 7.3% to 2.79B yen despite lower sales, indicating successful cost control initiatives. Gross profit margin stood at 29.1%, up from prior year levels. The improvement in operating profitability was driven by enhanced margins in the Gelatin Related segment, where operating income surged 58.2% to 1.76B yen with margin expansion to 18.8% from 11.1% in the prior year. Cosmetics segment operating income also grew 29.2% to 0.78B yen with margin improvement to 12.5%. However, the Collagen and Casing segment saw operating income decline 48.5% to 0.46B yen due to operational challenges and subsequent impairment of 432M yen for specialized production equipment. Ordinary income of 2.93B yen exceeded operating income by 0.14B yen, with non-operating income contributions including dividend income of 0.15B yen, interest income, and foreign exchange gains of 0.08B yen. The gap between ordinary income of 2.93B yen and net income of 1.98B yen (32.4% variance) is primarily attributable to the non-recurring impairment loss of 0.43B yen and tax expenses. Excluding the impairment, normalized net income would be approximately 2.41B yen, indicating that approximately 18% of the pre-tax earnings variance is due to non-recurring factors. This represents a revenue down, profit up pattern, where operational efficiency gains and segment mix improvements more than compensated for top-line pressure.
Gelatin Related segment is the core business with revenue of 9.32B yen (26.1% share) and operating income of 1.76B yen, representing 41.6% of total segment operating income and achieving the highest operating margin at 18.8%. This segment's profitability improved dramatically with operating income increasing 58.2% YoY. Food and Other segment contributed revenue of 8.08B yen (22.6% share) with operating income of 0.51B yen and margin of 6.3%. Collagen and Casing segment generated revenue of 6.78B yen (19.0% share) but operating income declined 48.5% to 0.46B yen, resulting in margin compression to 6.7% from 12.5% in the prior year, primarily due to withdrawal from unprofitable special specification products and associated impairment. Cosmetics segment produced revenue of 6.25B yen (17.5% share) with operating income of 0.78B yen and margin of 12.5%, improving from 10.5% YoY. Leather Related segment recorded revenue of 4.46B yen (12.5% share) with operating income of 0.10B yen and margin of 2.2%, reflecting challenging market conditions. Leasing and Real Estate segment, though smallest in revenue at 0.79B yen (2.2% share), achieved the highest margin at 78.1% with operating income of 0.62B yen. Material margin differentials exist, with Leasing and Real Estate and Gelatin Related segments demonstrating superior profitability structure compared to the more asset-intensive Leather Related and Collagen and Casing segments.
[Profitability] Operating margin improved to 7.8% from 6.9% YoY, demonstrating enhanced operational efficiency despite revenue headwinds. Net profit margin reached 5.5%, relatively stable compared to prior year. ROE of 4.8% remains below the company's 3-year average and reflects constrained capital efficiency. ROA of 2.8% indicates modest asset utilization relative to profitability generation. [Cash Quality] Cash and cash equivalents totaled 8.53B yen, providing coverage of 1.72 times short-term debt of 4.96B yen. Working capital efficiency shows room for improvement, with accounts receivable at 8.87B yen and inventory at 7.73B yen representing significant capital tied up in operations. [Investment Efficiency] Total asset turnover of 0.50 reflects the company's asset-intensive business model, below optimal levels for capital efficiency. Fixed asset turnover indicates ongoing utilization of property, plant and equipment in manufacturing operations. [Financial Health] Equity ratio of 57.3% demonstrates strong capitalization and financial stability. Current ratio of 184.1% and quick ratio of 134.6% indicate robust short-term liquidity position. Debt-to-equity ratio of 0.27 reflects conservative leverage, with interest-bearing debt of 11.17B yen well-covered by equity base. However, short-term debt represents a notable portion of total liabilities, requiring attention to refinancing risk management.
Cash and deposits increased modestly to 8.53B yen from 8.40B yen YoY, reflecting constrained cash generation amid operational headwinds. Working capital movements show accounts receivable increasing to 8.87B yen from 8.49B yen, indicating extended collection cycles or growing sales on credit terms. Inventory decreased to 7.73B yen from 7.89B yen, suggesting some progress in inventory management despite ongoing turnover concerns. Accounts payable declined significantly to 4.89B yen from 6.74B yen, representing accelerated supplier payments that consumed operating cash. This 1.85B yen reduction in payables represents a working capital outflow that offset operational cash generation. Short-term borrowings decreased marginally to 4.96B yen from 5.12B yen, while long-term debt increased slightly to 6.21B yen from 5.96B yen, suggesting modest refinancing activity. The company's liquid assets provide coverage of 1.72 times short-term debt, indicating adequate liquidity buffer. Total assets expanded to 71.54B yen, primarily driven by increases in investment securities and tangible fixed assets. The combination of working capital pressures, particularly the payables reduction, and limited cash growth suggests cash conversion efficiency warrants monitoring in subsequent periods.
Ordinary income of 2.93B yen versus operating income of 2.79B yen shows non-operating net contribution of approximately 0.14B yen, representing 4.8% of operating income. Non-operating income comprises primarily dividend income of 0.15B yen, interest income, and foreign exchange gains of 0.08B yen, partially offset by interest expenses and other non-operating costs. These non-operating items represent 0.4% of revenue and reflect primarily recurring financial income from investment holdings. Special items had material impact on earnings quality, with extraordinary losses of 0.43B yen primarily from impairment of specialized manufacturing equipment in the Collagen and Casing segment. This non-recurring loss represents 21.9% of net income, indicating that normalized earnings would be approximately 2.41B yen excluding the impairment. The impairment relates to strategic withdrawal from unprofitable overseas special specification products and is considered a one-time restructuring cost. While cash flow statement data is not available for quarterly reporting, balance sheet analysis indicates working capital management challenges with extended receivables collection and inventory turnover cycles. The payables reduction of 1.85B yen suggests cash outflow from operations that partially offsets reported profitability, raising questions about cash-backed earnings quality in the current period.
Progress rate versus full-year guidance shows revenue at 72.8% (35.67B yen actual versus 49.0B yen full-year forecast), operating income at 73.3% (2.79B yen versus 3.8B yen forecast), ordinary income at 77.1% (2.93B yen versus 3.8B yen forecast), and net income at 76.2% (1.98B yen versus 2.6B yen forecast) through Q3. These progress rates exceed the standard Q3 benchmark of 75%, indicating performance is tracking ahead of guidance on both revenue and profit metrics. The company maintains full-year forecasts of revenue 49.0B yen (YoY -0.3%), operating income 3.8B yen (YoY +4.8%), ordinary income 3.8B yen (YoY +5.1%), and net income attributable to owners 2.6B yen. No revisions to guidance were announced, suggesting management confidence in achieving targets. The Q3 progress rates imply Q4 would contribute approximately 13.3B yen in revenue and 1.0B yen in operating income to reach full-year targets. Given Q3 operating margin improvement and absence of anticipated non-recurring costs in Q4, the guidance appears achievable. Full-year EPS forecast of 904.11 yen corresponds to the net income target. The forecast implies Q4 revenue growth acceleration compared to Q3 run-rate, which may depend on seasonal factors and recovery in challenged segments, particularly Collagen and Casing following the restructuring actions taken in Q3.
Annual dividend is forecast at 633 yen per share for the full fiscal year, comprising interim and year-end payments. Based on the full-year net income forecast of 2.6B yen and the current EPS guidance of 904.11 yen, the dividend payout ratio would be approximately 70.0% of net income. The year-end dividend is planned at 600 yen per share. Comparing to prior period results, this represents continuation of the company's shareholder return commitment. With Q3 cumulative net income of 1.98B yen and the full-year dividend commitment of 633 yen per share, the annualized payout ratio based on current earnings trajectory is elevated. No share buyback program was disclosed in the current period materials. The total return ratio equals the payout ratio of approximately 70% in the absence of buyback activity. The dividend policy reflects management's confidence in full-year earnings delivery and commitment to shareholder returns, though the high payout ratio leaves limited room for earnings shortfalls and constrains retained earnings accumulation for growth investment or financial flexibility.
Inventory and working capital management present the most immediate operational risk, with inventory turnover days significantly above industry benchmarks and accounts receivable collection extending, together tying up approximately 16.6B yen in operating capital. This reduces financial flexibility and increases vulnerability to demand shocks or obsolescence, particularly in fashion-sensitive segments like cosmetics and leather. Segment concentration risk in Gelatin Related and Cosmetics segments, which together generate approximately 62% of operating profit, exposes earnings to market-specific downturns in these specialized materials and consumer product markets. The recent 432M yen impairment in Collagen and Casing demonstrates execution risk in international operations and specialized product lines. High dividend payout ratio of approximately 70% against backdrop of modest ROE of 4.8% creates sustainability tension, as the company must generate improved cash conversion to support dividends without depleting financial reserves. With operating cash flow quality concerns evident in working capital trends, sustained high payouts may constrain reinvestment capacity or require external financing if earnings disappoint.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: The company's operating margin of 7.8% positions below the manufacturing industry median of 8.7% (IQR: 5.1%-12.6%), indicating room for improvement in operational efficiency relative to peers. Net profit margin of 5.5% slightly trails the industry median of 6.4% (IQR: 3.3%-9.3%), reflecting the impact of non-recurring charges and suggesting profitability compression relative to sector norms. ROE of 4.8% falls below the industry median of 5.2% (IQR: 3.0%-8.3%), though within the interquartile range, indicating capital efficiency challenges that are common but improvable. ROA of 2.8% similarly tracks below the industry median of 3.3% (IQR: 1.8%-5.2%).
Financial Health: Equity ratio of 57.3% positions below the manufacturing industry median of 63.8% (IQR: 49.4%-74.5%), though remains within the interquartile range and reflects moderate leverage relative to peers. Current ratio of 184.1% significantly underperforms the industry median of 283.0% (IQR: 211.0%-380.0%), suggesting tighter liquidity management or higher short-term debt reliance compared to sector peers.
Efficiency: Asset turnover of 0.50 trails the industry median of 0.58 (IQR: 0.41-0.66), reflecting the company's more asset-intensive operations compared to the median manufacturer. Inventory turnover days significantly exceed industry norms, indicating material working capital efficiency gap. Receivables turnover days also extend beyond typical sector performance, contributing to working capital pressure.
Growth: Revenue contraction of -4.8% YoY materially underperforms the industry median growth of +2.8% (IQR: -1.7% to +8.1%), placing the company in the bottom quartile for top-line momentum. This growth gap represents the most significant competitive positioning concern relative to industry benchmarks.
Overall Position: The company occupies a below-median position across most key metrics relative to the manufacturing sector, with particular gaps in revenue growth, working capital efficiency, and liquidity ratios. Profitability and leverage metrics position near but below industry medians, indicating the company faces common sector challenges but has not yet achieved peer-leading performance in operational or capital efficiency.
(Industry: Manufacturing sector, N=100 companies, Comparison: 2025-Q3, Source: Proprietary analysis)
Operating efficiency improvements are materializing despite revenue headwinds, as evidenced by operating margin expansion to 7.8% from 6.9% YoY and 7.3% growth in operating income. This suggests management execution on cost structure optimization, particularly in the high-margin Gelatin Related segment where operating profit surged 58.2% and margins expanded to 18.8%. The successful restructuring of underperforming operations, including the strategic withdrawal from unprofitable overseas special specification products in Collagen and Casing, positions the business for improved profitability mix going forward once non-recurring impairment costs are absorbed.
Working capital management represents a critical area requiring continued attention, with accounts receivable, inventory, and payables dynamics indicating suboptimal cash conversion relative to reported earnings. The significant reduction in accounts payable from 6.74B yen to 4.89B yen consumed operating cash, while receivables and inventory turnover metrics trail industry benchmarks materially. Improvement in these operational metrics would directly enhance cash generation capacity and financial flexibility, particularly important given the elevated dividend payout commitment of approximately 70% of net income.
Earnings guidance tracking ahead of schedule through Q3 at 73-77% of full-year targets demonstrates business momentum and suggests management conservatism in initial planning or successful execution of operational improvements. The absence of guidance revisions despite Q3 non-recurring charges of 432M yen indicates confidence in Q4 delivery and underlying business resilience. However, achieving full-year targets requires approximately 13.3B yen Q4 revenue, implying sequential acceleration from Q3 run-rates that depends on seasonal patterns and recovery in challenged segments post-restructuring.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.